Skip to content
OpenCapital
Get started

Core Laboratories CLB EV / EBITDA

EV / EBITDA at other companies

Halliburton logo
HalliburtonHAL
9.3×+3.3×
Schlumberger logo
Schlumberger SLB
10.8×+4.5×
NCS Multistage Holdings logo
NCS Multistage HoldingsNCSM
41.9×—
Baker Hughes logo
Baker HughesBKR
11.6×—
Forum Energy Technologies logo
Forum Energy TechnologiesFET
13.2×—
RPC logo
RPCRES
6.9×+2.7×

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$492.77M-9.3%
Enterprise value$637.8M-7.6%
P/E17×-1.4×
P/S0.9×-0.1×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio2×-0.2×

Where this comes from

Calculated from Core Laboratories’s reported figures.

enterprise value/ebitda=13.4×

Based on the most recent quarter.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's EV / EBITDA?
Core Laboratories (CLB) reported EV / EBITDA of 13.4× in Q1 2026.
How has Core Laboratories's EV / EBITDA changed year-over-year?
Core Laboratories's EV / EBITDA increased by 7.7% year-over-year, from 12.4× to 13.4×.
What is the long-term trend for Core Laboratories's EV / EBITDA?
Over 3 years (2022 to 2025), Core Laboratories's EV / EBITDA has grown at a -13.7% compound annual growth rate (CAGR), from 19.4× to 12.5×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.